COX2 antibody and inflammation enzyme reagents: reading induction without over-reading it

Measuring induced enzymes

1. Establish the linear range before quantifying. A target that goes from nearly absent to abundant will saturate the detection long before the untreated lane is visible. Run a dilution series and choose an exposure where both ends are on scale.
2. Normalise to total protein. Housekeeping proteins change under the stimuli that induce these enzymes. Total protein staining is the safer normalisation and should be shown alongside.
3. Prepare microsomes for membrane bound enzymes. Drug metabolising enzymes sit in the endoplasmic reticulum, and a whole cell lysate dilutes them. A microsomal preparation concentrates them and is the conventional sample.
4. Measure secreted proteins in the medium. A secreted lectin or cytokine leaves the cell, so a lysate reports what has been made and not released. Measure both and say which is being reported.
5. Use a compartment marker as a control, not a result. Structural organelle markers are references for fractionation and imaging. Treating a change in one as a biological finding usually reflects a change in the preparation.
6. Pair induction with activity where the claim is functional. An induced enzyme is not necessarily an active one. Where the conclusion is about activity, an activity assay or a product measurement is what supports it.

Fold change is an exposure artefact until proven otherwise

When the baseline is at or below detection, the calculated fold change is a property of the exposure rather than of the biology. Reporting a large number from such a blot is common and indefensible.

Report the range in which the measurement was linear, and if the control lane is genuinely below detection, say that rather than dividing by it.

Induction and activity are separate claims for a COX-2 antibody

Protein appearing is not the same as flux through the enzyme, which depends on substrate, cofactors and post translational state. Both are measurable and they answer different questions.

Where the conclusion is about the pathway rather than the protein, add a product or activity measurement. It is usually a simpler experiment than the blot.

A ppar gamma antibody and the isoform question

PPAR gamma exists as two isoforms from alternative promoters with different tissue distribution, so a ppar gamma antibody should say which it detects and the expected masses belong in the method. It is a nuclear receptor whose activity depends on ligand rather than level, so an agonist treated lane and a target gene readout are what a figure needs beside the blot.

A ppar alpha antibody and the relative it is confused with

PPAR alpha shares a domain structure with the gamma and delta receptors, so a ppar alpha antibody needs cross reactivity data against them, and expression is highest in liver, which makes that tissue the positive control. As with the whole family, the informative measurement is a target gene response to a selective agonist rather than the receptor's abundance.

A foxo antibody and a family read by location

The FOXO factors are exported from the nucleus when phosphorylated by AKT, so a foxo antibody is read as a ratio between fractions or in an image rather than as a level, and the phospho clones name their residues. The family members are similar enough that a pan reactive clone is useful only for the family, and the isoform has to be named for any specific claim.

A foxa2 antibody and an endoderm lineage factor

FOXA2 marks endodermal and hepatic lineages and is used in differentiation protocols as a checkpoint, so a foxa2 antibody is scored as nuclear positivity in a proportion of cells with a stated stage. The forkhead domain is shared across the family, so specificity against FOXA1 in particular belongs in the datasheet, since the two are co-expressed in several tissues.

A foxm1 antibody and a proliferation associated factor

FOXM1 rises in proliferating cells and peaks in mitosis, so a foxm1 antibody reads a cycle position as well as an expression level, and an asynchronous population averages that away. It is phosphorylated extensively, which shifts its apparent mass and gives several bands. A synchronised positive control is what makes a comparison between lines meaningful.

A gata6 antibody and a factor with two literatures

GATA6 is a developmental factor in endoderm and heart and a marker in some cancers, so a gata6 antibody is interpreted against the tissue and the clone's validated application. The GATA family shares zinc finger sequence, so specificity against GATA4 in particular matters in cardiac work. It is nuclear, so a nuclear extract and a nuclear loading reference are the preparation.

Common questions

Why does my induced enzyme look infinitely induced?

Because the untreated lane is below detection at the exposure used. A dilution series and a longer exposure of the control, or a more sensitive substrate, put both ends on scale so a real fold change can be reported.

Do I need microsomes?

For membrane bound drug metabolising enzymes, yes. They are concentrated in a microsomal fraction and diluted in a whole cell lysate, which is why the conventional sample is the fraction.

Lysate or medium for a secreted protein beside an iNOS antibody?

Medium for what was released, lysate for what has been made and retained. They are different quantities and reporting one as the other is a common error.

Browse by service class

• Compare Gene synthesis on advertised prices